Alchemy Expands Multi-Chain Infrastructure With Support for Injective

According to a recent LinkedIn post from Alchemy, the blockchain infrastructure provider now supports Injective, a decentralized exchange-focused network with an order-book architecture at the protocol layer. The post highlights that this design aims to remove the need for developers to build core trading infrastructure themselves and emphasizes features such as shared liquidity, MEV-resistant execution, sub-second finality, and zero gas fees on trades.

The post cites Injective’s reported cumulative trading volume of more than $76 billion and over $6.5 billion in real-world asset derivatives volume, including tokenized gold, crude oil, and U.S. equities. It also references existing applications like Helix, which reportedly runs spot and perpetual markets on the native order book, and Joinn Finance, which is described as offering emerging market users access to Treasury yields and ETFs via the same infrastructure.

According to the post, Alchemy now provides core JSON RPC endpoints for Injective mainnet and testnet, positioning the integration as compatible with existing developer workflows on Alchemy for Ethereum and Solana. For investors, this suggests an expansion of Alchemy’s multi-chain infrastructure footprint into a specialized trading-focused ecosystem, potentially increasing developer engagement and transaction-related activity across its platform.

By adding Injective support, Alchemy may be aiming to capture more activity from DeFi and real-world asset tokenization projects that require high-performance order-book infrastructure. If this integration drives additional volume from trading and derivatives protocols building on Injective, it could enhance Alchemy’s role in servicing higher-value, transaction-intensive applications and strengthen its competitive positioning within blockchain infrastructure services.